Transthoracic intracardiac line use and complications in the paediatric single ventricle population

Nina Zook1, Justin Kochanski1, Shilpa Vellore Govardhan2

  • 1Department of Pediatric Cardiology, Stanford University, Palo Alto, CA, USA.

PubMed

Insights

Transthoracic intracardiac lines are safe for paediatric cardiothoracic surgery, especially in single ventricle patients. Surgical shunts increased complication risk, suggesting careful consideration for these lines.

Area of Science:

  • Cardiovascular Surgery
  • Pediatric Critical Care
  • Medical Device Safety

Background:

  • Transthoracic intracardiac lines offer vital postoperative access in pediatric cardiothoracic surgery.
  • Vascular preservation is critical for future interventions in single ventricle patients.
  • Limited data exists on transthoracic line complications in this population.

Purpose of the Study:

  • To evaluate the safety and complication rates of transthoracic intracardiac lines in pediatric single ventricle patients.
  • To identify factors associated with complications, including infection, thrombosis, malfunction, and migration.
  • To assess the suitability of transthoracic lines as an alternative to other central venous access methods.

Main Methods:

  • Retrospective review of pediatric single ventricle patients undergoing cardiothoracic surgery.
  • Data collected from 2011 to 2018 at a tertiary children's hospital.
  • Analysis of 338 transthoracic lines, focusing on complication types and associated factors.

Main Results:

  • Overall complication rate was 6.2% (21/338 lines).
  • Most common complications included migration (2.4%) and thrombosis (2.1%).
  • Presence of a surgical shunt was significantly associated with increased line complications (OR 2.58, P=0.03).

Conclusions:

  • Transthoracic intracardiac lines demonstrate a favorable safety profile in pediatric single ventricle patients.
  • These lines can be considered a primary alternative to other central lines in this population.
  • Further prospective studies are needed to optimize outcomes and protocols.